These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24390737)
21. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
22. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Lang Q; Ling C Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133 [TBL] [Abstract][Full Text] [Related]
23. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo. Wang W; Zhu F; Wang S; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S Oncol Rep; 2010 Jul; 24(1):183-8. PubMed ID: 20514460 [TBL] [Abstract][Full Text] [Related]
24. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition. Xu X; Jiang C; Wang S; Tai Y; Wang T; Kang L; Fan Z; Li S; Li L; Fu J; Liu J; Ji Q; Wang X; Wei L; Ye Q IUBMB Life; 2013 Oct; 65(10):873-82. PubMed ID: 24038948 [TBL] [Abstract][Full Text] [Related]
25. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor. Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321 [TBL] [Abstract][Full Text] [Related]
26. HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription. Liang Y; Fan Y; Liu Y; Fan H Exp Cell Res; 2021 Dec; 409(1):112898. PubMed ID: 34737140 [TBL] [Abstract][Full Text] [Related]
27. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D. Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649 [TBL] [Abstract][Full Text] [Related]
28. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma. Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin. Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302 [TBL] [Abstract][Full Text] [Related]
32. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner. Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016 [TBL] [Abstract][Full Text] [Related]
34. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Fang F; Yang L; Tao Y; Qin W Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761 [TBL] [Abstract][Full Text] [Related]
35. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk. Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801 [TBL] [Abstract][Full Text] [Related]
36. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011 [TBL] [Abstract][Full Text] [Related]
37. The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia. Park SJ; Kim JG; Son TG; Yi JM; Kim ND; Yang K; Heo K Biochem Biophys Res Commun; 2013 May; 434(4):722-7. PubMed ID: 23583388 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells. Zhang X; Hu S; Zhang X; Wang L; Zhang X; Yan B; Zhao J; Yang A; Zhang R Biochem Biophys Res Commun; 2014 Jan; 443(3):1078-84. PubMed ID: 24370822 [TBL] [Abstract][Full Text] [Related]
39. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584. Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]